BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20858485)

  • 1. Detection of EBV in nasopharyngeal carcinoma by quantum dot fluorescent in situ hybridization.
    Chen HL; Peng J; Zhu XB; Gao J; Xue JL; Wang MW; Xia HS
    Exp Mol Pathol; 2010 Dec; 89(3):367-71. PubMed ID: 20858485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
    Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
    Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.
    Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P
    Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization.
    Mirzamani N; Salehian P; Farhadi M; Tehran EA
    Exp Mol Pathol; 2006 Dec; 81(3):231-4. PubMed ID: 16787643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
    Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
    N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Epstein-Barr virus infection in gastric carcinomas using quantum dot-based fluorescence in-situ hybridization.
    Peng J; Chen HL; Zhu XB; Yang GF; Zhang ZL; Tian ZQ; Pang DW
    J Nanosci Nanotechnol; 2011 Nov; 11(11):9725-30. PubMed ID: 22413281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
    Tsai ST; Jin YT; Mann RB; Ambinder RF
    Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
    Burgos JS; Vera-Sempere FJ
    Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In situ hybridization in undifferentiated nasopharynx carcinoma in Tunisia. Report of 3 cases].
    Baizig Nehla M; Hamouda B; Asma K; Farhat BA; Abderahmen L; Omrane BH; Ahmed el M
    Tunis Med; 2001 Oct; 79(10):544-7. PubMed ID: 11910697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
    Brousset P; Butet V; Chittal S; Selves J; Delsol G
    Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detecting Epstein-Barr virus in nasopharyngeal carcinoma tissue using in situ polymerase chain reaction].
    Xu L; Yang X; Xie L
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):17-8. PubMed ID: 11776587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA.
    Chan KC; Lo YM
    Methods Mol Biol; 2006; 336():111-21. PubMed ID: 16916257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
    Liu JP; Cassar L; Pinto A; Li H
    Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma: Epstein-Barr Virus significance.
    Kottaridis SD; Panotopoulou E; Diamantis I; Goula I; Danilidis J; Fountzilas G
    Anticancer Res; 1996; 16(2):785-9. PubMed ID: 8687129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization.
    Chen PC; Pan CC; Yang AH; Wang LS; Chiang H
    J Pathol; 2002 Aug; 197(5):684-8. PubMed ID: 12210090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of Epstein-Barr virus in lung carcinoma tissue by in situ hybridization].
    Li CM; Han GL; Zhang SJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):288-90. PubMed ID: 17971949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.